
iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF (IHE) Price & Chart
IHE ETF Chart & Stats
- Day’s Range
- $109.43 - $112.29
- 52-Week Range
- $80.25 - $112.29
- Previous Close
- $111.03
- Volume
- 155.16K
- Average Volume (3M)
- 243.97K
- AUM
- 1.74B
- NAV
- 109.59
- Expense Ratio
- 0.37%
- Holdings Count
- 54
- Beta
- 0.41
- Inception Date
- May 01, 2006
- Last Dividend Ex-Date
- Sep 15, 2026
- Dividend Yield
- (1.31%)
- Shares Outstanding
- 15,650,000
- Standard Deviation
- N/A
ETF Overview
iShares U.S. Pharmaceuticals ETF
The iShares U.S. Pharmaceuticals ETF (IHE) is a specialized investment vehicle designed for those looking to gain exposure to the rapidly evolving pharmaceuticals sector within the broader health care industry. As a sector-focused ETF, IHE provides investors with targeted access to a niche market that plays a pivotal role in global health and innovation. By investing in a diversified portfolio of U.S.-based pharmaceutical companies, this ETF offers an opportunity to capitalize on the growth potential and resilience of firms involved in the development, production, and marketing of drugs and treatments that address a wide range of medical conditions. IHE is particularly appealing to investors seeking to tap into the cutting-edge advancements and robust demand for pharmaceutical products, driven by an aging global population and ongoing medical breakthroughs. This fund provides a unique blend of stability and growth potential, as pharmaceuticals are often seen as a defensive sector with the ability to perform well across various economic cycles. With iShares U.S. Pharmaceuticals ETF, investors can seamlessly access a curated selection of industry leaders, from established giants to emerging innovators, thus positioning their portfolios to benefit from the dynamic landscape of health care solutions.
- Asset Class
- Equity
- Region
- North America
- Issuer
- iShares
- Index Tracked
- DJ US Select / Pharmaceutical
- Ticker Symbol
- IHE
IHE ETF News



IHE ETF FAQ
What was IHE’s price range in the past 12 months?
What is the AUM of IHE?
Is IHE overvalued?
Does IHE pay dividends?
How many shares outstanding does IHE have?
Which hedge fund is a major shareholder of IHE?
IHE ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 26.73% |
| JNJJohnson & Johnson | 22.20% |
| VTRSViatris, Inc. | 4.90% |
| ZTSZoetis | 4.83% |
| RPRXRoyalty Pharma PLC | 4.75% |
| PFEPfizer Inc | 4.36% |
| MRKMerck & Company | 4.11% |
| BMYBristol-Myers Squibb Company | 4.10% |
| JAZZJazz Pharmaceuticals | 3.20% |
| ELANElanco Animal Health | 2.71% |
| Total | 81.88% |












